Find all needed information about Bonesupport Holding Ab. Below you can see links where you can find everything you want to know about Bonesupport Holding Ab.
https://www.bonesupport.com/
BONESUPPORT AB is a Scandinavian orthobiologics company that develops and markets CERAMENT ®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to host bone in six to twelve months. Our products are effective in treating patients with fractures and bone voids …
https://www.bonesupport.com/en-eu/financial-reports/
BONESUPPORT HOLDING AB was listed on Nasdaq Stockholm on 21st June 2017 and interim reports are published from Q2 2017. Financial Reports 2019. Financial Reports 2018. Financial Reports 2017. Other Reports
https://news.cision.com/bonesupport-holding-ab/r/bonesupport-holding-ab-signs-an-agreement-on-a-working-capital-facility-of-sek-60-million,c3024601
5 hours ago · BONESUPPORT HOLDING AB signs an agreement on a working capital facility of SEK 60 million Fri, Jan 31, 2020 12:00 CET. Lund, Sweden, 12:00 pm CET, 31 January 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the company has signed an agreement with Skandinaviska Enskilda …
https://www.bonesupport.com/en-eu/financial-reports-2019/
BONESUPPORT HOLDING AB was listed on Nasdaq Stockholm on 21st June 2017 and interim reports are published from Q2 2017. Interim Report, Q3, July - September 2019. 7th November 2019 08:00 CET. Net sales amounted to SEK 39.1 million (14.2), an increase of 175%.
https://www.bloomberg.com/quote/BONEX:SS
About BoneSupport Holding AB BoneSupport Holding AB operates as a pharmaceutical company. The Company develops and distributes bio ceramic composites, bone graft substitutes, and other products.Employees: 80
https://finance.yahoo.com/quote/BONEX.ST/
Find the latest BONESUPPORT HOLDING AB (BONEX.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.
https://www.bonesupport.com/en-us/investors-us-3.html
The company is based in Lund, Sweden, and the net sales amounted to SEK 97 million in 2018. Please visit www.bonesupport.com for more information. BONESUPPORT TM and CERAMENT ® are registered trademarks. For more information contact: BONESUPPORT AB. Emil Billbäck, CEO +46 (0) 46 286 53 70. Håkan Johansson, CFO +46(0) 46 286 53 70. ir ...
https://www.bonesupport.com/en-eu/pr0735-01-en-eu.html
Lund, Sweden, 08.45 CET, 17 May 2018 – BONESUPPORT HOLDING AB (publ) announces today that the current distribution agreement has been terminated and will be replaced by a network of independent distributors and its own commercial organization.This will allow BONESUPPORT to increase its market penetration while creating a stronger platform for …
https://www.bonesupport.com/en-eu/prospectus.pdf
present Prospectus, “BONESUPPORT”, the “Company”, or the “Group” means, depending of the context, BONESUPPORT HOLDING AB, a subsidiary in the group or the group in which BONESUPPORT HOLDING AB is the Parent Company. “Carnegie” refers to Carnegie Investment Bank AB (publ) and “ABGSC” refers to ABG Sundal Collier AB. Carnegie and
https://www.bonesupport.com/en-us/pr0943-01-en-us.html
I consent to the use of cookies. Share Price. BONESUPPORT: 38,20 SEK-1,04%. 12:11 CEST 31 Jan 2020
https://www.bonesupport.com/
BONESUPPORT AB is a Scandinavian orthobiologics company that develops and markets CERAMENT ®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to host bone in six to twelve months.
https://www.bonesupport.com/en-eu/financial-reports/
BONESUPPORT HOLDING AB was listed on Nasdaq Stockholm on 21st June 2017 and interim reports are published from Q2 2017. Financial Reports 2019 Financial Reports 2018
https://www.bonesupport.com/en-eu/pr0735-01-en-eu.html
Lund, Sweden, 08.45 CET, 17 May 2018 – BONESUPPORT HOLDING AB (publ) announces today that the current distribution agreement has been terminated and will be replaced by a network of independent distributors and its own commercial organization. This will allow BONESUPPORT to increase its market penetration while creating a stronger platform for current products and future launches in the US market.
https://www.bonesupport.com/en-eu/financial-reports-2019/
BONESUPPORT HOLDING AB was listed on Nasdaq Stockholm on 21st June 2017 and interim reports are published from Q2 2017. Interim Report, Q3, July - September 2019. 7th November 2019 08:00 CET. Net sales amounted to SEK 39.1 million (14.2), an increase of 175%.
https://www.bloomberg.com/quote/BONEX:SS
BoneSupport Holding AB operates as a pharmaceutical company. The Company develops and distributes bio ceramic composites, bone graft substitutes, and other products. Bone Support …Employees: 80
https://www.marketscreener.com/BONESUPPORT-HOLDING-AB-P-35897700/news/Bonesupport-publ-HOLDING-AB-signs-an-agreement-on-a-working-capital-facility-of-SEK-60-million-29919870/
1 day ago · This information is such information as BONESUPPORT HOLDING AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 12:00 pm CET on 31 January 2020.
Need to find Bonesupport Holding Ab information?
To find needed information please read the text beloow. If you need to know more you can click on the links to visit sites with more detailed data.
